This site is intended for health professionals only
With society reopened in many countries, non-COVID-19 viruses are potentially circulating again.
The causes and types of respiratory tract infections (RTIs) are wide and can be difficult to discriminate by symptoms alone.
Rapid identification of the underlying cause of respiratory illness can guide appropriate clinical decisions, helping to improve patient outcomes and patient workflows.
The next-generation high sensitivity microfluidic technology on the LumiraDx Platform contains some of the key assays for respiratory pathogens and biomarkers* on one platform, helping identify and differentiate the underlying cause of respiratory illness and helping inform treatment decisions at the point of care.
Find out more about our Respiratory tests: